CINP is pleased to introduce the Daniela Parolaro Prize, established in collaboration with the Zardi–Gori Foundation for Addiction Research. The prize recognizes researchers who are making impactful contributions to the field of addiction science and aims to support the next generation of leaders in neuropsychopharmacology. Nominations are now open - discover more about the prize, eligibility criteria, and how to apply. Deadline for application: |
The CINP Early Careers Committee is pleased to announce the CINP Research Fellowships 2026, aimed at supporting early-career researchers and clinicians working in the field of neuropsychopharmacology. This year’s theme - Neuropsychopharmacology of Addiction and Substance Use - focuses on the neuropsychopharmacology of addiction and substance use, exploring cutting-edge research and clinical perspectives that advance our understanding of substance use disorders. The programme includes online teaching modules with top researchers in their fields as well as an in-person colloquium that will take place immediately before the CINP 2026 Congress in Glasgow on 26th June 2026. Deadline for application: |
We are delighted to announce the recipients of the CINP Student Encouragement Award 2026:
The CINP Fellowship and Awards Committee decided to also award several President's Special Commendation Diplomas to appreciate the high quality of the received applications. Congratulations to all awardees! |
Introducing CINP 2026 Keynote Speakers:
Professor David Nutt (UK) Professor David Nutt is Professor of Neuropsychopharmacology at Imperial College London and a globally recognised leader in psychopharmacology. His career spans clinical medicine, academic leadership, public policy, and groundbreaking research. From neurotransmitter function in anxiety, depression, and addiction to the neuroscience and clinical applications of psychedelics, Professor Nutt’s work has had a lasting impact on the field. His keynote lecture at CINP 2026 in Glasgow will be: Why Psychedelics are the Future of Neuropsychopharmacology
|
We are proud to announce that CINP 2026 will collaborate with Glasgow Children’s Hospital Charity to support the National Child Psychiatry Unit (Ward 4) at the Royal Hospital for Children in Glasgow. Ward 4 is the only unit of its kind in Scotland, caring for children under 12 from across the country. Many patients stay for months at a time, making safe, supportive, and creative environments essential to their care and wellbeing. During CINP 2026, the Charity will also host a charity shop at the congress venue, where participants can support this important work by purchasing merchandise and souvenirs and learn more about the charity activities. Join us in Glasgow and be part of something meaningful - together, we can support children, families, and clinical teams when it matters most. |
We are excited to announce the preparation of an International Course in Psychopharmacology, designed for residents in psychiatry and neurology, psychiatrists, neurologists, and general practitioners, and everybody who wishes to deepen their understanding of the mechanisms and clinical applications of psychopharmacological treatments. Through this program, CINP seeks to foster global learning, professional development, and the dissemination of evidence-based neuropsychopharmacology. The course will be online, CME-accredited, with sessions held every Thursday for several consecutive weeks. The first edition of the course is planned for the second half of 2026. More information coming soon! |
GLOBAL
| International Journal of Neuropsychopharmacology
Impact Factor: 3.7 |
-
January 30, 2026 10:48
-
December 17, 2025 15:46
-
October 27, 2025 16:13
